💊 SBI Backs Sun Pharma’s Global Expansion

State Bank of India (SBI) is set to commit up to $1 billion towards financing Sun Pharma’s proposed $12 billion acquisition of Organon & Co. The move highlights the increasing participation of Indian public sector banks in funding large-scale cross-border acquisitions. The transaction reflects the growing global ambitions of Indian corporates, with Sun Pharma aiming to strengthen its international presence through one of the largest deals in the pharmaceutical sector. SBI’s involvement alongside global lenders signals confidence in the strategic importance of the acquisition.